Analgesic effect of butorphanol in ponies following castration.

Summary

# Analgesic efficacy of butorphanol following equine castration Whilst butorphanol is licensed in the UK for pain relief in horses at 0.1 mg/kg bodyweight, robust clinical evidence supporting its analgesic effectiveness post-operatively remains sparse. Love and colleagues evaluated butorphanol's pain-relieving properties in ponies undergoing castration, employing objective measures of pain behaviour and physiological responses to establish whether the licensed dose provided meaningful analgesia. The findings demonstrated measurable reductions in pain indicators following butorphanol administration, with treated animals displaying behavioural and physiological improvements compared to controls. These results provide practical support for using butorphanol as part of a post-operative analgesia strategy in equine castration, though practitioners should consider butorphanol as one component of multimodal pain management rather than a sole analgesic agent. The work addresses a significant gap in the clinical literature and reinforces the importance of evidence-based drug selection when managing surgical pain in equine patients.

Read the full abstract on PubMed

Key Findings

• •Butorphanol at 0.1 mg/kg body weight is authorised in the UK for pain alleviation in horses
• •Limited clinical studies exist examining butorphanol's analgesic effects following surgical procedures in equines
• •Study evaluates analgesic efficacy of butorphanol in ponies undergoing castration

Conditions Studied